Hyaluronic acid/Chitosan nanoparticles as delivery vehicles for VEGF and PDGF-BB

Drug Delivery

Volumn 17, Issue 8, 2010, Pages 596-604

  Parajó, Yolanda ^a   D'Angelo, Ivana ^a   Welle, Alexander ^b   Garcia Fuentes, Marcos ^a   Alonso, María José ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

Angiogenesis; Chitosan; Growth factors; Hyaluronic acid; Nanoparticles; Tissue engineering

Indexed keywords

BOVINE SERUM ALBUMIN; CHITOSAN; DRUG CARRIER; HEPARIN; HYALURONIC ACID; NANOPARTICLE; PLATELET DERIVED GROWTH FACTOR BB; STABILIZING AGENT; VASCULOTROPIN;

ARTICLE; CELL CULTURE; CELL LINE; CONCENTRATION (PARAMETERS); CULTURE MEDIUM; CYTOTOXICITY; DRUG DELIVERY SYSTEM; ENCAPSULATION; FEMALE; GELATION; HUMAN; HUMAN CELL; IN VITRO STUDY; METHODOLOGY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; VASCULARIZATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; CARCINOMA, HEPATOCELLULAR; CATTLE; CELL LINE, TUMOR; CHITOSAN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HEPARIN; HUMANS; HYALURONIC ACID; ISCHEMIA; NANOPARTICLES; NEOVASCULARIZATION, PHYSIOLOGIC; PLATELET-DERIVED GROWTH FACTOR; SERUM ALBUMIN, BOVINE; TISSUE ENGINEERING; TRANSPLANTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77957739081     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2010.509357     Document Type: Article

References (63)

1. Aktas, Y., Andrieux, K., Alonso, M.J., Calvo, P., Gürsoy, R.N., Couvreur, P., Çapan, Y. (2005). Preparation and in vitro evalu-ation of chitosan nanoparticles containing a caspase inhibitor. Int J Pharm. 298:378-83.
2. Allison, D.D., Grande-Allen, K.J. (2006). Hyaluronan: a powerful tissue engineering tool. Tissue Eng. 12:2131-40.
3. Alonso-Sande, M., Cuña, M., Remuñán-Lopez, C., Teijeiro-Osorio, D., Alonso-Lebrero, J.L., Alonso, M.J. (2006). Formation of new glucomannan-chitosan nanoparticles and study of their abil-ity to associate and deliver proteins. Macromolecules. 39: 4152-58.
4. Aragona, P. (2004). Hyaluronan in the treatment of ocular surface dis-orders. In: Chemistry and Biology of Hyaluronan, Editors: Hari G. Garg, Charles A. Hales, Publisher Location: Amsterdam (Te Netherlands) Elsevier, 529-51.
5. Babensee, J.E., McIntire, L.V., Mikos, A.G. (2000). Growth factor deliv-ery for tissue engineering. Pharm Res. 17:497-504.
6. Boniece, I.R., Wagner, J. (1993). Growth factors protect PC12 Cells against ischemia by a mechanism that is independent of PKA, PKC, and protein synthesis. J Neurosci. 13:4220-28.
7. Boontheekul, T., Mooney, D.J. (2003). Protein-based signaling systems in tissue engineering. Curr Opin Biotechnol. 14:559-65.
8. Calvo, P., Remuñán-López, C., Vila-Jato, J.L., Alonso, M.J. (1997a). Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci. 63:125-32.
9. Calvo, P., Remuñan-López, C., Vila-Jato, J.L., Alonso, M.J. (1997b). Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vac-cines. Pharm Res.14:1431-36.
10. Cao, Y., Hong, A., Schulten, H., Post, M.J. (2005). Update on therapeu-tic neovascularisation. Cardiovas Res. 65:639-48.
11. Cetin, M., Aktas, Y., Vural, I., Capan, Y., Dogan, L.A., Duman, M., Dalkara, T. (2007). Preparation and in vitro evaluation of bFGF-loaded chitosan nanoparticles. Drug Delivery. 14:525-9.
12. Chen, R.R., Mooney, D.J. (2003). Polymeric Growth factor delivery strategies for tissue engineering. Pharm Res. 20:1103-12.
13. Chen, R.R., Silva, E.A., Yuen, W.W., Mooney, D.J. (2007). Spatiotemporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res. 24:258-64.
14. Chou, Y.F., Chen, H.H., Eijpe, M., Yabuuchi, A., Chenoweth, J.G., Tesar, P., Lu, J., McKay, R.D.G., Geijsen, N. (2008). Te growth factor environment defnes distinct pluripotent ground states in novel blastocyst-derived stem cells. Cell. 135:449-61.
15. Csaba, N., Köping-Höggård, M., Alonso, M.J. (2009). Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery. Int J Pharm. 382:205-1.
16. Cuña, M., Alonso-Sande, M., Remuñan-Lopez, C., Pivel, J.P., Alonso-Lebrero, J.L., Alonso, M.J. (2006). Development of phosphorylated glucomannan-coated chitosan nanoparticles as nanocarriers for protein delivery. J Nanosci Nanotechnol. 6:2887-95
17. d'Angelo, I., Alonso, M.J. (2007). PLGA-poloxamer blend based nanoparticles as delivery vehicles for proangiogenic factors. 1st Conference on 'Innovation in Drug Delivery: From Biomaterials to Devices, Napoli (Italy
18. d'Angelo, I., Alonso, M.J. (2008). PLGA-poloxamer blend based particles as delivery vehicles for proangiogenic factors. Nanomedicines 08 Workshop, Patras (Greece).
19. de la Fuente, M., Raviña, M., Paolicelli, P., Sánchez, A., Seijo, B., Alonso, M.J. (2010). Chitosan-based nanostructures: a delivery platform for ocular therapeutics. Adv Drug Del Rev. 62:100-17.
20. de la Fuente, M., Seijo, B., Alonso, M.J. (2008a). Bioadhesive hyaluronchitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue. Gene Terapy. 15:668-76.
21. de la Fuente, M., Seijo, B., Alonso, M.J. (2008b). Novel hyaluronic acidchitosan nanoparticles for ocular gene therapy. Invest Ophth Vis Sci 49:2016-24.
22. de la Fuente, M., Seijo, B., Alonso, M.J. (2008c). Novel hyaluron-based nanocarriers for transmucosal delivery of macromolecules. Macromol Biosci. 8:441-50.
23. de la Fuente, M., Seijo, B., Alonso, M.J. (2008d). Design of novel polysaccharidic nanostructures for gene delivery. Nanotechnology. DOI: 10.1088/0957-4484/19/7/075105. (Pubitemid 351225273)
24. Delgado, J.J., Evora, C., Sánchez, E., Baro, M., Delgado, A. (2006). Validation of a method for non-invasive in vivo measurement of growth factor release from a local delivery system in bone. J Control Release. 114:223-9.
25. Fernández-Urrusuno, R., Calvo, P., Remuñán- López, C., Vila-Jato, J.L., Alonso, M.J. (1999). Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm Res. 16:1576-81.
26. Ferrara, N. (1999). Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77:527-43.
27. Ferrara, N. (2001). Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 280:1358-66.
28. Ferrara, N., Gerber, H.P., LeCouter, J. (2003). Te biology of VEGF and its receptors. Nat Med. 9:669-76.
29. Gaiti, N., Aserin, A. (1996). Double emulsions stabilized by macromolecular surfactants. Adv Coll Inter Sci. 65:37-69.
30. Garcia-Fuentes, M., Torres, D., Alonso, M.J. (2003). Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Coll Surf B Biointerfaces. 27:159-68.
31. Gu, F., Neufeld, R., Amsden, B. (2007). Maintenance of vascular endothelial growth factor and potentially other therapeutic proteins bioactivity during a photo-initiated free radical crosslinking reaction forming biodegradable elastomers. Eur J Pharm Biopharm. 66:21-7.
32. Hasthorpe, S., Barbic, S., Farmer, P.J., Hutson, J.M. (2000). Growth factor and somatic cell regulation of mouse gonocyte-derived colony formation in vitro. J Reprod Fertil. 119:85-91.
33. Hosack, L.W., Firpo, M.A., Scott, J.A., Prestwich, G.D., Peattie, R.A. (2008). Microvascular maturity elicited in tissue treated with cytokine-loaded hyaluronan-based hydrogels. Biomaterials. 29:2336-47.
34. Huang, M., Vitharana, S.N., Peek, L.J., Coop, T., Berkland, C. (2007). Polyelectrolyte complexes stabilize and controllably release vascular endothelial growth factor. Biomacromolecules. 8:1607-14.
35. Ibrahim, S., Ramamurthi, A. (2008). Hyaluronic acid cues for functional endothelialization of vascular constructs. J Tissue Eng Reg Med 2:22-32.
36. Janes, K.A., Calvo, P., Alonso, M.J. (2001). Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev. 47:83-97.
37. Kelm, J.M., Diaz Sanchez-Bustamante, C., Ehler, E., Hoerstrup, S.P., Djonov, V., Ittner, L., Fussenegger, M. (2005). VEGF profling and angiogenesis in human microtissues. J Biotechnol. 118:213-29.
38. Koch, S., Yao, C.H., Grieb, G., Prével, P., Noah, E.M., Stefens, G.C.M. (2006). Enhancing angiogenesis in collagen matrices by covalent incorporation of VEGF. J Mater Sci Mater Med. 17:735-41.
39. Lapick, L. Jr., Lapick L. Jr., Desmedt, S., Demeester, J., Charbrecek, P. (1998). Hyaluronan: preparation, structure, properties and applications. Chem Rev. 98:2663-83.
40. Lee, J.Y., Nam, S.H., Im, S.Y., Park, Y.J., Lee, Y.M., Seol, Y.J., Chung, C.P., Lee, S.J. (2002). Enhanced bone formation by controlled growth factor delivery from chitosan-based biomaterials. J Control Release. 78:187-97.
41. Lee, K.W., Yoon, J.J., Lee, J.H., Kim, S.Y., Jung, H.J., Kim, S.J., Joh, J.W., Lee, H.H., Lee, D.S., Lee, S.K. (2004). Sustained release of vascular endothelial growth factor from calcium-induced alginate hydrogels reinforced by heparin and chitosan. Trans Proceed. 36:2464-5.
42. Liao, I.C., Wan, A.C.A., Yim, E.K.F., Leong, K.W. (2005). Controlled release from fbers of polyelectrolyte complexes. J Control Release. 10:347-58.
43. López-León, T., Carvalho, E.L.S., Seijo, B., Ortega-Vinuesa, J.L., Bastos-González, D.J. (2005). Physicochemical characterization of chitosan nanoparticles: electrokinetic and stability behaviour. Colloid Interf Sci. 283:344-51.
44. Morlock, M., Koll, H., Winter, G., Kissel, T. (1997). Microencapsulation of rh-erythropoietin, using biodegradable poly(D,L-lactide-coglycolide):protein stability and the efects of stabilizing excipients. Eur J Pharm Biopharm. 43:29-36.
45. Mundargi, R.C., Babu, V.R., Rangaswamy, V., Patel, P., Aminabhavi, T.M. (2008). Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. J Control Release. 125:193-209.
46. Nasti, A., Zaki, N.M., de Leonardis, P., Ungphaiboon, S., Sansongsak, P., Rimoli, M.G., Tirelli, N. (2009). Chitosan/TPP and chitosan/TPP-hyaluronic acid nanoparticles: systematic optimisation of the preparative process and preliminary biological evaluation. Pharm Res. 26:1918-30.
47. Nomi, M., Atala, A., De Coppi, P., Soker, S. (2002). Principals of neovascularization for tissue engineering. Mol Aspects Med. 23:463-83.
48. Oyarzun-Ampuero, F.A., Brea, J., Loza, M.I., Torres, D., Alonso, M.J. (2009). Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma. Int J Pharm. 381:122-9.
49. Pike, D.B., Cai, S., Pomraning, K.R., Firpo, M.A., Fisher, R.J., Shu, X.Z., Prestwich, G.D., Peattie, R.A. (2006). Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials. 27:5242-51.
50. Prego, C., Paolicelli, P., Diaz, B., Vicente, S., Sánchez, A., González-Fernández, A., Alonso, M.J. (2010). Chitosan based nanoparticles for improving immunization against hepatitis B infection. Vaccine. 28:2607-14.
51. Raines, E.W., Bowen-Pope, D.F., Ross, R. (1991). Platelet-derived growth factor. In: Sporn, M.B., Roberts, A.B., eds. Peptide growth factors and their receptors. New York: Springer, 173-262.
52. Ravi Kumar, M.N.V. (2000). A review of chitin and chitosan applications. React Funct Polym. 46:1-27.
53. Richardson, T.P., Peters, M.C., Ennett, A.B., Mooney, D.J. (2001). Polymeric system for dual growth factor delivery. Nat Biotechnol 19:1029-34.
54. Rolny, C., Spillmann, D., Lindah, U., Claesson-Welsh, L. (2002). Heparin amplifes platelet-derived growth factor (PDGF)-BB-induced PDGF β-receptor but not PDGF β-receptor tyrosine phosphorylation in heparan sulfate-defcient cells. J Biol Chem. 277:19315-21.
55. Sánchez, A., Villamayor, B., Guo, Y., McIver, J., Alonso, M.J. (1999). Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres. Int J Pharm. 185:255-66.
56. Shi, C., Zhu, Y., Ran, X., Wang, M., Su, Y., Cheng, T.J. (2006). Potential of chitosan and its derivatives in regenerative medicine. Surg Res. 133:185-92.
57. Soker, S., Machado, M., Atala, A. (2000). Systems for therapeutic angiogenesis in tissue engineering. World J Urol. 18:10-18.
58. Sokolsky-Papkov, M., Agashi, K., Olaye, A., Shakeshef, K., Domb, A.J. (2007). Polymer carriers for drug delivery in tissue engineering. Adv Drug Deliv Rev. 59:187-206.
59. Vila, A., Sánchez, A., Tobio, M., Calvo, P., Alonso, M.J. (2002). Design of biodegradable particles for protein delivery. J Control Release. 78:15-24.
60. Yancopoulos, G.D., Davis, S., Gale, N.W., Rudge, J.S., Wiegand, S.J., Holash, J. (2000). Vascular-specifc growth factors and blood ves-sel formation. Nature. 407:242-8.
61. Yi, F., Wu, H., Jia, G.L. (2006). Formulation and characterization of poly (D,L-lactide-co-glycolide) nanoparticle containing vascular endothelial growth factor for gene delivery. J Clin Pharm Ter. 31:43-8.
62. Zavan, B., Vindigni, V., Vezzù, K., Zorzato, G., Luni, C., Abatangelo, G., Elvassore, N., Cortivo, R. (2009). Hyaluronan based porous nano-particles enriched with growth factors for the treatment of ulcers: a placebo-controlled study. J Mater Sci Mater Med 20:235-47.
63. Zisch, A.H. (2004). Tissue engineering of angiogenesis with autologous endothelial progenitor cells. Curr Opin Biotechnol. 15:424-9.